Chae‐Ok Yun

机构：Genexine (South Korea), Hanyang University, Korea Institute of Science and Technology, Anyang University · ORCID：0000-0002-9466-4531

发表论文 385 篇 · 总被引 11051 次 · h-index 60

代表论文

• Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis (2024 · Cell Death and Disease · 被引 26)
• Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here? (2023 · Cancer Letters · 被引 23)
• CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer (2024 · Molecular Therapy · 被引 19)
• Smart Accumulating Dual-Targeting Lipid Envelopes Equipping Oncolytic Adenovirus for Enhancing Cancer Gene Therapeutic Efficacy (2024 · ACS Nano · 被引 18)
• Potent therapeutic efficacy of intranasally deliverable paclitaxel modified with pH-sensitive and PEGylated polymeric micelle against glioblastoma (2025 · Journal of Controlled Release · 被引 13)
• Ethyl Pyruvate Decreases Collagen Synthesis and Upregulates MMP Activity in Keloid Fibroblasts and Keloid Spheroids (2024 · International Journal of Molecular Sciences · 被引 9)